Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF AUGUST 11, 2022 SAM #7559
SPECIAL NOTICE

66 -- Notice of Intent to Sole Source: Procurement of CellGenix GMP rh IL-4 Reagent for Cancer Vaccine Clinical Trials

Notice Date

8/9/2022 7:54:18 AM
 

Notice Type

Special Notice
 

NAICS

325414 — Biological Product (except Diagnostic) Manufacturing
 

Contracting Office

NIH NCI ROCKVILLE MD 20852 USA
 

ZIP Code

20852
 

Solicitation Number

75N91022Q00169
 

Response Due

8/15/2022 9:00:00 AM
 

Point of Contact

Lena Lee, Contract Specialist, Reyes Rodriguez, Contracting Officer
 

E-Mail Address

lena.lee@nih.gov, reyes.rodriguez@nih.gov
(lena.lee@nih.gov, reyes.rodriguez@nih.gov)
 

Description

PLEASE SEE ATTACHED PDF The National Cancer Institute (NCI), Center for Cancer Research (CCR), Vaccine Branch (VB) requires CellGenix GMP rh IL-4 reagent for cancer vaccine clinical trials. The Office of Acquisitions (OA) plans to procure, on a sole source basis, the IL-4 reagent from CellGenix USA (One New Hampshire Ave. Ste. 125 Portsmouth, NH 03801-2907). The response close date of this notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 � Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(1); and is exempt from the requirements of FAR Part 6.� The North American Industry Classification System code is 325414 � Biological Product (except Diagnostic) Manufacturing.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/b4b18ec419b843819c47a49903307af8/view)
 

Place of Performance

Address: Bethesda, MD 20892, USA

Zip Code: 20892

Country: USA
 

Record

SN06419077-F 20220811/220809230115 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |